Liver scarring becomes treatable
Advanced scarring from fatty-liver disease has no approved treatment today. Three drugs are in late-stage trials to change that.
55%likely
Well sourced
Next check
Digging in
Why it is different
Three drugs are racing for the first-ever approval in advanced liver cirrhosis, and most people still write the whole area off.
Why it matters
Right now this ends in a transplant or death. A first approval creates a standard of care where none exists.
Next check · 31 Dec 2026
Does Novo Nordisk publish its SYNCHRONY Real-World Phase 3 headline result by 31 Dec 2026 with no new safety problem in the cirrhosis group?
How we scored it ·
from how often this kind of thing happens
If right, how big4/5How overlooked3/5Upside vs downside4/5Source trust4/5Independent sources5/5
The exact wording we score
An F4-specific approval in compensated MASH cirrhosis lands by end-2031, from a three-horse set named today.